New advances in the diagnosis of primary aldosteronism
- PMID: 32226929
- PMCID: PMC7096326
- DOI: 10.1016/j.cdtm.2019.12.009
New advances in the diagnosis of primary aldosteronism
Abstract
Primary aldosteronism (PA) is a common form of endocrine hypertension. The diagnostic process of PA includes a screening test, confirmatory test, and subtype classification. In this review, we have summarized the latest advances in the diagnosis of PA with regard to screening and confirmatory tests and provided some recommendations to improve clinical practice.
Keywords: Confirmatory test; Primary aldosteronism; Screening test.
© 2020 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Conflict of interest statement
None.
References
-
- Funder J.W., Carey R.M., Mantero F. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–1916. - PubMed
-
- Loh K.C., Koay E.S., Khaw M.C., Emmanuel S.C., Young W.F., Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854–2859. - PubMed
-
- Sang X., Jiang Y., Wang W. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens. 2013;31:1465–1471. discussion 1471-1472. - PubMed
-
- Rossi G.P., Bernini G., Caliumi C. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–2300. - PubMed
Publication types
LinkOut - more resources
Full Text Sources